12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PleuraFlow System with FlowGlide

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

VEO® Lateral Interbody Fusion System

FDA UDI
Choice Spine, LP·00840996133272·LATERAL,COBB DISSECTOR,STRAIGHT SHAFT

UNISIGHT SYSTEM WITH UNIGATE

FDA 510(k)
FDA Class 2 ·Radiology

APPALEAD GW+03XXXXXXR SERIES

FDA 510(k)
FDA Class 2 ·Cardiovascular

PULSE GEN MODEL 101

FDA Adverse Event
Malfunction ·CYBERONICS, INC.·Product code LYJ·October 15, 2008

ASKU

FDA Adverse Event
Malfunction ·MEDTRONIC, INC.·Product code DQX·August 11, 2011

HEARTMATE II LVAS

FDA Adverse Event
Injury ·THORATEC CORPORATION·Product code DSQ·July 2, 2013

MEDTRONIC TRANSCATHETER VALVE

FDA Adverse Event
Injury ·MEDTRONIC HEART VALVES DIVISION·Product code NPT·November 22, 2023

Spacelabs Healthcare elance Vital Signs Monitor, Model 93300, with Option S. It is a patient monitor with arrhythmia detection or alarms.

FDA Enforcement
Class II ·Terminated·Spacelabs Healthcare, Llc·November 20, 2013

EMBLEM MRI S-ICD Model A219

FDA Enforcement
Class I ·Terminated·Boston Scientific Corporation·February 17, 2021

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

EMBLEM MRI S-ICD pulse generators, as part of Boston Scientific S-ICD System; Model A219

FDA Enforcement
Class II ·Ongoing·Boston Scientific Corporation·February 3, 2021